A Comparative study on Tamaka Shwaasa (Bronchial Asthma) with Ashtaangaavaleha and Vyaaghreeharetakee Avaleha in Children - NO, there is no designated trial acronym

The Director0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Diagnosed cases of Tamaka Shwasa Bronchial Asthma with at least 3 episodes of asthma symptoms during the previous year
•Severity as mild to moderate stable asthma defined by FEV 1 more than 60 persent and less than 80 persent of that predicted by Polgar equation
•Able to generate a peek inspiratory flow rate of 60 L per minute
•Patients on other drug therapy will be included only after completion of wash out period prescribed
•Parents legal guardians willing to give written informed consent

•Evidence of active concomitants pulmonary disease other than asthma
•Evidence of requirement of intubations for asthma, or had been hospitalized for asthma within one month before
•Had unresolved sinus disease or an unresolved upper or lower respiratory tract infection within 3 weeks
•More than 4 short courses of oral corticosteroids within the year preceding the screening visit, or any oral corticosteroids in the preceding 4 weeks
•Use of Astemizole, Nedocromil, Cromolyn, long acting β agonists, Ketotifen, or Theophylline within 2 weeks before
•Concomitant severe decompensated systemic disease (cardiovascular, renal, hepatic, endocrine, hematological, neurological, immunological)

发起方

The Director